Search Results - Jamie LESNOCK
- Showing 1 - 5 results of 5
-
1
Use of indocyanine green dye for sentinel lymph node mapping in patients with endometrial cancer and a history of iodinated contrast allergy by Zainab Balogun, Alysia Wiener, Jessica Berger, Jamie Lesnock, Alison A. Garrett
Published in Gynecologic Oncology Reports (2024-10-01)Get full text
Article -
2
-
3
Beyond GOG258 and PORTEC3: A National Cancer Database analysis of adjuvant therapy for improved survival in high-risk endometrial cancer by Megan E Lander, John Vargo, Runjia Li, G.K. Balasubramani, Ron Buckanovich, Jamie Lesnock, Alison Garrett, Shannon Rush, Paniti Sukumvanich
Published in Gynecologic Oncology Reports (2025-06-01)Get full text
Article -
4
Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer by Lan G. Coffman, Taylor J. Orellana, Tianshi Liu, Leonard G. Frisbie, Daniel Normolle, Kent Griffith, Shitanshu Uppal, Karen McLean, Jessica Berger, Michelle Boisen, Madeleine Courtney-Brooks, Robert P. Edwards, Jamie Lesnock, Haider Mahdi, Alexander Olawaiye, Paniti Sukumvanich, Sarah E. Taylor, Ronald Buckanovich
Published in JCI Insight (2022-09-01)Get full text
Article -
5
Clinical factors associated with failed sentinel lymph node mapping in endometrial cancer by Alison A. Garrett, Alyssa Wield, Brigid Mumford, Isabel Janmey, Li Wang, Philip Grosse, Emily MacArthur, Ronald Buckanovich, Madeleine Courtney-Brooks, Paniti Sukumvanich, Jessica Berger, Alexander B. Olawaiye, Haider Mahdi, Michelle Boisen, Robert P. Edwards, Lan Coffman, Sarah E. Taylor, Jamie Lesnock
Published in Gynecologic Oncology Reports (2022-12-01)Get full text
Article
